.svg){kind=small}
Apr-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the competitive cannabis market of New York, Jumbodose has shown remarkable consistency in the Tincture & Sublingual category. Over the first four months of 2024, the brand maintained a solid third-place ranking, demonstrating its strong presence and consumer preference in this segment. While the sales figures fluctuated slightly, with a notable dip in March to $66,739 before rebounding to $78,208 in April, this pattern suggests a resilient demand for Jumbodose's offerings. The consistent ranking amidst these sales fluctuations highlights the brand's stable market position in New York, a key insight for stakeholders tracking performance trends in the state's cannabis industry.
However, the analysis of Jumbodose's performance across other states or provinces and categories remains incomplete in this dataset, providing a limited view of the brand's overall market footprint. The absence of data beyond the Tincture & Sublingual category in New York means we cannot fully assess Jumbodose's performance diversity or its standing in other competitive arenas. This gap underscores the importance of broader market intelligence for a comprehensive understanding of Jumbodose's market dynamics. Nevertheless, the available information paints a picture of a brand that has secured a loyal consumer base in a specific category, which is an essential foundation for any cannabis brand looking to expand its reach in the highly fragmented and competitive market landscape.
Competitive Landscape
In the competitive landscape of the Tincture & Sublingual category in New York, Jumbodose has consistently held the third rank from January to April 2024, demonstrating stability in its market position. Despite this steady rank, Jumbodose has experienced fluctuations in sales, with a notable dip in March before recovering in April. Its main competitors, Head & Heal and Ayrloom, have maintained the first and second ranks respectively throughout the same period, with Head & Heal showing a significant lead in sales, indicating a strong preference among consumers. Notably, OMO - Open Minded Organics moved up to the fourth position in February and maintained it, showing a potential challenge to Jumbodose's position, especially considering OMO's upward sales trend. Veterans Choice Creations (VCC), despite a drop to the fifth rank in February and disappearing from the top ranks in March, returned in April, indicating a volatile but persistent presence in the market. This analysis suggests that while Jumbodose has a solid foothold, the dynamic shifts and sales trends of its competitors could impact its market share and necessitate strategic adjustments to maintain or improve its position.
Notable Products
In April 2024, Jumbodose saw the Hybrid Mega Tincture (1000mg THC, 30ml) leading its product sales with 333 units, marking its position at the top of the sales chart. Following closely was the CBD/THC 5:1 Chill Tincture (1500mg CBD, 300mg THC, 30ml), which secured the second rank, showing a slight decline from its top position in March. The CBG/THC 5:1 Focus Tincture (1500mg CBG, 300mg THC, 30ml) came in third, maintaining a consistent presence in the top three across the previous months. The CBN/THC 5:1 Doze Tincture (1500mg CBN, 300mg THC, 30ml) was ranked fourth, illustrating a significant recovery in sales compared to its performance in February and March. These rankings highlight a competitive landscape within Jumbodose's Tincture & Sublingual category, with notable shifts in consumer preferences month over month.
Top Selling Cannabis Brands
